Triamcinolone Acetonide
Drugsingle intraarticular injection of 40 mg of triamcinolone acetonide
NCT Number: NCT00746889
A study using characteristics on ultrasound to predict response to intraarticular steroid injections in patients with knee osteoarthritis. The hypothesis is that patients with inflammation on ultrasound will have a better response to corticosteroid injections compared to patients without inflammation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
San Diego VA Hospital, La Jolla, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
single intraarticular injection of 40 mg of triamcinolone acetonide
Single intraarticular injection of 1 ml of 0.9% saline
Time frame: baseline to 4 weeks
WOMAC pain subscale range 0-20 (0=best, 20=worst)
Time frame: baseline to 12 weeks
WOMAC pain subscale range 0-20 (0=best, 20=worst)
University of California, San Diego
Other
Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis: A Randomized Placebo-Controlled Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07720024
Arthritis, Blount disease
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial DetailsNCT01818401
Arthritis, Joint Diseases
Nantes, France
View Trial DetailsNCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details